dalteparin has been researched along with Brain Diseases in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
Excerpt | Relevance | Reference |
---|---|---|
"Forty-three major postoperative hemorrhages (1." | 2.71 | Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study. ( Beck, J; Gerlach, R; Raabe, A; Scheuer, T; Seifert, V; Woszczyk, A, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gerlach, R | 1 |
Scheuer, T | 1 |
Beck, J | 1 |
Woszczyk, A | 1 |
Seifert, V | 1 |
Raabe, A | 1 |
1 trial available for dalteparin and Brain Diseases
Article | Year |
---|---|
Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study.
Topics: Adult; Aged; Anticoagulants; Bandages; Brain Diseases; Drug Administration Schedule; Female; Humans; | 2003 |